Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin for Lung Cancer Prevention in Former Smokers
NCT00414960Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2007
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enzastaurin in lung cancer, sponsored by Eli Lilly and Company. Started Dec 2007; status: completed.
02
Drugs
enzastaurin
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00414960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414960.